S&P revises Massachusetts Ear and Eye’s outlook to negative

S&P Global Ratings revised Boston-based Massachusetts Ear and Eye’s outlook to negative from stable.

Advertisement

“The negative outlook reflects our view of MEE’s continued operating losses, by our calculation, and weak coverage of pro forma maximum annual debt service” said S&P analyst Jennifer Soule.

The ratings agency also affirmed the “BBB-” long-term rating on the institution’s series 2010 hospital revenue bonds.

More articles on healthcare finance:
Fitch affirms ‘BBB+’ rating on Silver Cross Health System’s bonds
Fitch affirms ‘BB+’ rating on Marshall Medical Center’s bonds
Moody’s affirms ‘A1’ rating on Children’s National Medical Center’s bonds

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.